Abstract Objective: Colonic carcinoma is one of the most common cancers worldwide. Recently, the possible involvement of claudin-1, one of the major tight junction proteins, in the process of tumorigenesis has been suggested. Also, claudin-1 has emerged as a potential prognostic factor in different types of tumors. The aim of this study was to detect caludin-1 expression in colonic carcinoma and to correlate its expression with clinicopathological variables in an attempt to delineate its role as a potential new prognostic marker. Material and methods: Immunohistochemical expression of claudin-1 was assessed in 50 Egyptian patients with colonic adenocarcinoma. The predictive performance of claudin-1 expression was statistically evaluated. Results: Decreased claudin-1 expression was found in 62% of colonic adenocarcinoma cases while similar expression was found in 38%. Statistical analysis showed a statistically significant inverse correlation between claudin-1 expression and tumor grade, depth of invasion, lymph node involvement, and tumor stage. Regression analysis showed that claudin-1 decreased expression significantly predicts that the tumor is of a high grade, high stage, and is associated with lymph node involvement. ROC curve analysis showed that claudin-1 had a sensitivity of 88.24% and a specificity of 81.25% for the prediction of tumor stage and a sensitivity of 73.33% and a specificity of 82.86% for the prediction of lymph node involvement. Conclusions: Claudin-1 decreased expression in colonic carcinoma contributes to tumor dedifferentiation, invasion and metastasis. Claudin-1 expression could be used as a predictor of colonic carcinoma stage and lymph node status with a high sensitivity and specificity.
Introduction
Colonic carcinoma is the fourth most common cancer worldwide with an estimated one million new cases and a half million deaths each year [1] . In Africa colonic carcinoma accounts for just 2.5% of all cancers compared to 9.5% in developed countries [2] . According to the Egyptian National Cancer Institute, colonic carcinoma in Egypt contributes 6.5% of all cancers [3] .
It is now clear that colonic carcinoma results from a multistep accumulation of genetic alterations in proto-oncogenes, tumor suppressor genes and DNA repair genes [4] . In sporadic colonic carcinoma, these alterations are acquired, and are likely to be caused by exogenous and endogenous carcinogens. In contrast, in cancer syndromes, critical genetic alterations that predispose to malignancy are inherited [5] .
Due to the increasing incidence of colonic carcinoma, several studies have been done in an attempt to understand its pathogenesis and assess the most valuable prognostic factor [6] . Pathologic staging of colonic carcinoma is the best available clinicopathologic prognostic marker, however, there is an urgent need to find markers that can stratify patients better and earlier according to their risk of colonic carcinoma recurrence and overall survival [7] . In recent years a large number of prognostic markers have been suggested for colonic carcinoma [8] [9] [10] .
Evidence for altered tight junctions in carcinomas has been known for more than 30 years [11] . Observations in examined tumors include attenuation or lack of tight junctions, increased paracellular permeability, and reductions in the number of tight junction strands which all result in a decrease in the epithelial barrier function of cells. Therefore, the loss of tight junctions appears to constitute an essential step in cancer development [11] [12] [13] [14] . Tight junction proteins also play critical roles in cellular proliferation and neoplastic pathways via their functions as transmitters of the extracellular environment to intracellular signaling pathways [15] .
Claudins are a large family of essential tight junction proteins [16] . There are two major functions defined for claudins: the regulation of paracellular permeability and maintenance of the cell polarity [16] .
The impact of claudin dysregulation deserves attention, as it is now clear that these proteins play a role in tumorigenesis and represent promising new targets for cancer diagnosis, prognosis and therapy [17, 18] .
A multitude of studies reported down-regulation and upregulation of various claudins in various cancers [19] . However, only little information is available on the influence of claudin expression on tumor behavior. Also, relatively few studies have examined the role of claudins in the tumorigenesis and prognosis of colonic carcinoma [20] .
So far, 24 members of the claudin family have been identified [21] . Claudin-1 which is ubiquitously expressed in many organs, is thought to be a universal marker of tight junctions and is alleged to be associated with the development of various cancers [22] . However, the significance of claudin-1 expression in cancer cells is not well understood [23] . In colonic carcinoma, the molecular and morphological alterations of claudin-1 are still poorly understood [24] [25] [26] .
The aim of this study was to detect caludin-1 expression in colonic carcinoma and to correlate its expression with clinicopathological variables in an attempt to delineate its role as a potential new prognostic marker.
Material and methods

Patients and tissue samples
The present work included 50 cases of colonic carcinomas that were retrieved from the surgical pathology archives at the Pathology Department, Faculty of Medicine, the Alexandria University between the years 2004 and 2009. Complete clinical data were available for all patients. None of these patients received pre-operative adjuvant chemotherapy or radiotherapy.
Pathological examination
Routinely processed paraffin-embedded tissues were cut into 5 lm-thick sections and stained with the conventional H&E stain. Each case was carefully reviewed and graded according to the WHO classification system of gastrointestinal tumors [27] . In addition, the stage of the tumor was established according to the AJCC staging system [28] .
Immunohistochemistry for claudin-1
Tissue sections (5 lm) were deparaffinized in xylene and rehydrated through graded ethanol to water. Hydrogen peroxide was applied to block endogenous peroxidase activity. Antigen retrieval was performed by boiling tissue sections in 10 mM citrate buffer, pH 6.0. Slides were then incubated with the primary antibody (claudin-1, rabbit polyclonal antibody, ready to use). The bound antibody was detected by the UltraVision Detection System (Anti-Polyvalent, HRP/DAB, readyto-use). Both the primary antibody and the detection kit were purchased from the Lab Vision Corporation (Neo Markers, Fremont, USA). Immunohistochemical staining was performed using an avidin-biotinylated immunoperoxidase methodology. Both positive and negative controls were included in all runs.
Assessment of Immunostaining
A case was considered claudin-1 positive if any number of tumor cells showed membranous and/or cytoplasmic positivity [19] . Both the intensity and the extent of claudin-1 immunostaining were evaluated in tumor tissue as well as in the adjacent normal mucosa which served as an internal control.
The intensity of staining was graded as either weak = 1; moderate = 2; or strong = 3. The extent of staining was evaluated semiquantitatively and categorized as focal (610%) = 1; regional (11-50%) = 2; or diffuse (P50%) = 3.
Total scores for caludin-1 expression were then calculated by multiplying the obtained scores of both intensity and extent of staining [19] .
Total scores of claudin-1 expression in the studied colonic carcinoma cases were compared to the adjacent normal mucosa and a final computed score for each case was calculated (by subtraction of the total score in normal mucosa from the total score in the tumor) [19] .
In cases where total scores for claudin-1 expression in the tumor were equal to the adjacent normal mucosa (final score = 0), the tumor was designated as having similar claudin-1 expression to normal mucosa.
If the total score for claudin-1 expression in the tumor was less than that in the normal mucosa (final score less than 0), the tumor was designated as having decreased claudin-1 expression.
If the total claudin-1 staining score in the tumor was higher than the normal mucosa; (final score more than 0), the tumor was designated as having increased claudin-1 expression.
Statistical analysis
Data were analyzed using Predictive Analytics Software (PASW Statistics 18). Significance of the obtained results was judged at the 5% level.
Non-parametric tests such as the Wilcoxon Mann-Whitney test, Kruskal-Wallis test, and Spearman's rho correlation were used.
Regression analysis was done. Linear models were developed aiming to identify the independent variable while controlling other variables.
The predictive performance of claudin-1 expression in colonic carcinoma was evaluated using Receiver Operating Characteristic (ROC) curve analysis. The cutoff point at which the highest predictive accuracy was reached was estimated using Youden Index.
Results
Clinicopathologic study
The age of the patients ranged from 17 to 75 years (mean: 52.6, median: 53.5). 18 patients (36%) were males and 32 patients (64%) were females with a M:F ratio of 1:1.8.
The most commonly involved part by the tumor was the cecum (12 cases, 24%) followed by the ascending colon (10 cases, 20%), the sigmoid colon (nine cases, 18%), the descending colon (seven cases, 14%), the transverse colon (six cases, 12%), and the rectosigmoid area (six cases, 12%).
Microscopically, all cases were classified as adenocarcinoma (NOS). Histological grading was done according to the WHO grading system. Twenty-three cases (46%) were well differentiated, 18 cases (36%) were moderately differentiated and nine cases (18%) were poorly differentiated.
The 50 cases included in this study were staged according to AJCC staging system. The tumor invasion was limited to the submucosa (T1) in only two cases (4%). Muscularis propria invasion (T2) was noted in 15 cases (30%). In 31 cases (62%) the tumor reached the subserosa (T3) while in two cases (4%) the tumor directly invaded nearby organs or structures (T4).
As regards lymph node metastasis, 33 cases (66%) were designated as N0 while seven cases (14%) were designated as N1 and 10 cases (20%) were designated as N2.
A total of 48 cases (96%) showed no distant metastasis (M0), while only two cases (4%) showed distant metastasis (M1) to the liver.
Finally, stage grouping was done and 14 cases (28%) were stage I, 20 cases (40%) were stage II, 14 cases (28%)were stage III, and two cases (4%) were stage IV.
Immunohistochemical study
Immunoreactivity was interpreted without prior knowledge of any of the clinicopathologic parameters. Both the tumor and adjacent normal colonic mucosa were separately scored for claudin-1 expression.
The normal colonic mucosa showed diffuse claudin-1 staining with a strong intensity in all the studied cases. The staining pattern was membranous with accentuation of the lateral rather than apical borders. Cytoplasmic staining was also noted. The total score for normal mucosa was nine in all of the studied cases. No staining was observed in the stroma (Fig. 1a) .
Claudin-1 expression in colonic adenocarcinomas (Fig. 1b-f ) was assessed regarding staining extent and intensity. The extent of staining ranged from focal (eight cases, 16%) to regional (19 cases, 38%) to diffuse (23 cases, 46%). Staining intensity was strong in 30 cases (60%), moderate in nine cases (18%) and weak in 11 cases (22%). Total scores ranged from 1 to nine with a mean of 5.84 ± 2.999.
The staining pattern was circumferential membranous and/ or cytoplasmic in well and moderately differentiated tumors. An incomplete membranous pattern was focally noted in moderately differentiated tumors. In poorly differentiated tumors, the staining pattern was mainly cytoplasmic with minimal incomplete membranous staining.
Claudin-1 expression in the studied colonic adenocarcinoma cases was similar to the normal colonic mucosa in 19 cases (38%) and showed decreased expression in 31 cases (62%) where the final scores ranged from À3 to À8 (mean = À5.0968, median = À5). None of the studied colonic adenocarcinoma cases showed increased claudin-1 expression. Table 1 illustrates the distribution of claudin-1 expression regarding tumor grade, depth of invasion, lymph node involvement and tumor stage.
Relation between claudin-1 expression and clinicopathological parameters (Table 2 ): statistical analysis showed that the relation between claudin-1 expression on one hand and age, sex and tumor location on the other hand was insignificant (Spearman's rho = À0.093, p = 0.522, Mann-Whitney U = 201.000, p = 0.067, X 2 = 8.490, p = 0.131 respectively).
A statistically significant strong inverse correlation was detected between claudin-1 expression on one hand and tumor grade, lymph node status, and tumor stage in the other hand (Spearman' rho = À0.676, p < 0.000, Spearman's rho = À0.592, p < 0.000, and Spearman's rho = À0.640, p < 0.000 respectively). In addition, a statistically significant, yet weak, inverse correlation was found between claudin-1 expression and depth of tumor invasion (Spearman's rho = À0.280, p = 0.049) (Fig. 2) .
Final score for claudin-1 expression in the two colonic carcinoma cases associated with metastasis (mean = À8, median = À8) was lower than the final claudin-1 score in cases not associated with metastasis (mean = À2.958, median = À3). However, statistical analysis could not be done due to small number of the cases.
Regression analysis and ROC curve analysis
The clinicopathological factors found to be significantly correlated with claudin-1 expression (the tumor grade, stage, depth of tumor invasion and lymph node status) were subjected to further regression statistical analysis. Three regression models were generated to overcome the problem of multicollinearity (Table 3) .
From the developed models, claudin-1 decreased expression was found to be a significant independent predictor for tumor grade, stage and lymph node status. Decreased claudin-1 expression significantly predicts that the tumor is of a high grade, high stage, and is associated with lymph node involvement (p < 0.001, p < 0.001, and p = 0.013 respectively).
A step further in analysis, ROC curve analysis was carried out in order to detect a cut off value for claudin-1 expression at which the highest predictive accuracy was reached. The grade was omitted from the analysis since tumor grade can be easily assessed histologically by light microscopic examination. A cutoff point was determined at final score À5 (Fig. 3) .
At the cutoff point of À5, claudin-1 showed a sensitivity of 88.24% and a specificity of 81.25% for the prediction of tumor stage. The positive likelihood ratio was 4.71 and the negative likelihood ratio was 0.14. Predictive values were calculated with a positive predictive value of 90.9% and a negative predictive value of 76.5%. The predictive power was good (area under the curve = 0.892, 95% CI = 0.772-0.962, p = <0.000).
As regards lymph node involvement, at the cutoff point of À5, claudin-1 showed a sensitivity of 73.33% and a specificity of 82.86% for the prediction of lymph node status. The positive likelihood ratio was 4.28 and the negative likelihood ratio was 0.32. Predictive values were calculated with a positive predictive value of 64.7% and a negative predictive value of 87.9%. The predictive power was good (area under the curve = 0.839, 95% CI = 0.708 to 0.927, p = <0.000).
Discussion
Worldwide, every year more than one million individuals will develop colonic carcinoma, and disease specific mortality rate is nearly 33% in the developed world [29] . Advances in molecular carcinogenesis, prognostic and predictive molecular markers have been recently developed [1, 30, 31] . Among these markers are markers for tight junctions [32] . The role of adherent junction proteins has been studied extensively in cancer, but the roles of tight junction proteins are less well understood [33] . Disruption of the cell-cell junction with concomitant changes in the expression of junctional proteins is central to the cellular transformation and acquisition of metastatic potential [33] .
Claudins are integral to the structure and function of tight junctions [33] . Recent studies show changes in expression/cellular localization of claudins during tumorigenesis; however, a causal relationship between claudin expression/localization and cancer has not been definitely established [26] .
In the present study, 50 cases of colonic adenocarcinomas were immunohistochemically studied for claudin-1 expression. The nearby normal colonic mucosa was used as an internal control and was also assessed for claudin-1 expression for comparison. The extent, intensity and pattern of claudin-1 staining in normal colonic mucosa were similar to the results reported by other investigators [15, 19] who reported that the claudin-1 staining was cytoplasmic with accentuation of the lateral cell membrane. In contrast Resnick et al. [15] reported a circumferential claudin-1 immunostaining in the normal colonic mucosa.
As regards the studied colonic adenocarcinoma cases, a greater number of cases (31 cases, 62%) showed decreased claudin-1 expression as compared to 19 cases (38%) that showed similar claudin-1 expression to the normal colonic mucosa. This result is in line with several previous studies reported by Hahn-Stro¨mberg et al. [34] and Miwa et al. [35] . These authors reported a decreased claudin-1 expression in colonic adenocarcinomas. Also Tokes et al. [36] reported a decreased claudin-1 expression in invasive breast carcinoma as compared to the normal breast ducts.
The mechanisms underlying the decreased claudin-1 expression in colonic carcinoma remain unknown. It is not quite as clear how down-regulation of claudins may contribute to the neoplastic progression [20] . However, it has been proposed that decreased expression of claudin-1 with the loss of cell polarity is followed by an abnormal influx of different growth factors, which give rise to auto-and paracrine stimulations of neoplastic epithelia and thus provides nutrition factors and other factors necessary for tumor cell growth [37, 38] . Also, it was proved that the injured structure and function of tight junctions might disorder the cell proliferation and differentiation and thus encourage the carcinogenesis [39] . A statistically significant strong inverse correlation was found between claudin-1 expression and the tumors' grade in the current study. These findings are in accordance with those reported by Matsuoka et al. [40] , Tzelepi et al. [41] and Resnick et al. [15] who reported that decreased expression of claudin-1 is significantly associated with higher tumor grade and poor differentiation. Moreover, Cha et al. [42] suggested that claudin-1 expression may be correlated with the progression of colonic carcinoma.
In addition, Higashi et al. [22] reported that attenuated expression of claudin-1 closely correlates with the dedifferentiation of hepatocellular carcinoma and concluded that down-regulated claudin-1 expression may thus serve as a potential marker for a poor prognosis in hepatocellular carcinoma.
The results of our study together with other reports [18] suggest that the decrease of claudin-1 expression in colonic carcinoma of higher grade due to its down-regulation might contribute to the more aggressive behavior of the tumors. This could be explained by the fact that the preservation of cell polarity and paracellular flux by many claudin molecules suggests that these proteins contribute to tumor suppressive functions in epithelial neoplasia [43] . In addition, changes in or loss of expression of tight junction proteins such as claudins can lead to cellular disorientation and detachment, which are commonly seen in neoplasia [44] .
In the present work, a statistically significant inverse correlation was found between claudin-1 expression and depth of tumor invasion. This is in accordance with the findings reported by Tokes et al. [36] who reported a decreased claudin-1 expression in invasive breast carcinoma. This phenomenon was explained by Chao et al. [45] who studied claudin-1 expression in lung carcinoma. They reported that overexpression of claudin-1 suppressed cancer cell migration, invasion and metastasis. They thus concluded that claudin-1 is a cancer invasion and metastasis suppressor.
In contrast to our findings, Kingusa et al. [46] , Leotlela et al. [47] and others [35, 38] reported overexpression of claudin-1 in invasive tumor cells. They explained their findings by the fact that claudins are able to interact with membrane-type matrix metalloproteinases (MT-MMPs) and thus promote MMP activity. They thus concluded that claudin overexpression seems to be an early event in carcinogenesis at least for some cancer types.
Also, in this study, a statistically significant strong inverse correlation was seen between claudin-1 expression and lymph node involvement. Ersoz et al. [48] reported similar results and concluded that claudin-1 expression in colonic carcinoma was significantly decreased with lymph node metastasis. These findings were also in agreement with those reported by Cha et al. [42] .
These findings were explained by the fact that a modification in the tight junction function and structure may affect tumor penetration, [49] and that loss of claudins and other tight junction proteins account for the loss of cell adhesion which is an important step in the development of tumor invasion and metastasis [50] .
On the other hand, several authors reported an increase in claudin-1 expression in metastatic carcinomas [26, 45] . The reason for the discrepancy observed in claudin expression among the different tissues is unclear but may be related to tissuespecific differences in claudin function or even in the tissue microenvironmental factors [51] . The discrepancy could also be explained by the differences in methodology and antibodies used.
In the present study, claudin-1 expression was also correlated with the tumor stage which is until now considered the most important prognostic factor in colonic carcinoma [52] . A statistically significant strong inverse correlation was found between claudin-1 expression and tumor stage. These results are in accordance with those reported by Matsuoka et al. [40] who stated that a reduced expression of claudin-1 was correlated with advanced tumor stage.
Also, the results are in agreement with other recent studies [20, 35, 53] . These studies highlighted the role that claudin-1 plays in invasion and metastasis and tumor progression. In contrast, Gro¨ne et al. [54] showed no clear correlation between claudin-1 expression and tumor stage.
In the present work, regression analysis showed that claudin-1 decreased expression was a significant independent predictor for tumor grade, stage and lymph node status. Decreased claudin-1 expression significantly predicts that the tumor is of a high grade, high stage, and is associated with lymph node involvement.
An additional statistical test was done to delineate a cut off point that significantly discriminates between low and high stage tumors as well as predicts lymph node status. A cutoff point was determined at a final score of À5.
At the cutoff point of À5, claudin-1 showed a sensitivity of 88.24% and a specificity of 81.25% for the prediction of tumor stage as well as a sensitivity of 73.33% and a specificity of 82.86% for the prediction of lymph node status. The predictive power was good. Accordingly, claudin-1 decreased expression with a final score of 6À5 significantly predicts that the tumor is of high stage (III or IV) and is associated with lymph node metastasis. On the other hand, if claudin-1 final score is > À5, it significantly predicts that the tumor is of low stage (I or II) and is associated with negative lymph nodes.
Thus, the level of claudin-1 expression could predict the stage and lymph node status of an individual patient. However, these results need to be supported by further studies on a larger scale of patients.
From the present work it can be concluded that, claudin-1 is consistently expressed in non-neoplastic colonic mucosa which emphasizes its important role in maintaining the normal function and morphology of colonocytes. Claudin-1 may be involved in the process of colonic tumorigenesis. Claudin-1 decreased expression contributes to the progression and dedifferentiation of colonic carcinoma and it may underlie the invasive and metastatic potential of colonic carcinoma. Immunohistochemical claudin-1 expression could be used as a predictor of colonic carcinoma stage as well as lymph node status with a high sensitivity and specificity.
